NCT00302848View on ClinicalTrials.gov

European Active Surveillance Study (EURAS)

CompletedOBSERVATIONAL
Enrollment

59,510

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

December 31, 2005

Conditions
Contraception
Interventions
DRUG

Drospirenone

DRUG

Levonorgestrel

DRUG

Other progestin containing oral contraceptive

Trial Locations (1)

10115

Center for Epidemiology and Health Research, Berlin

All Listed Sponsors
collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT00302848 - European Active Surveillance Study (EURAS) | Biotech Hunter | Biotech Hunter